1. A25 Metabolism of sialo-conjugates is defective in pre-clinical models of huntington's disease. (September 2018) Authors: Pepe, Giuseppe; Amico, Enrico; Castaldo, Salvatore; Capocci, Luca; Boltje, Thomas J; Pardo, Alba Di; Maglione, Vittorio Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89(2018)Supplement 1 Page Start: A9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. B37 Aberrant sphingosine-1-phosphate metabolism as druggable target in huntington's disease. (13th September 2016) Authors: Pardo, Alba Di; Amico, Enrico; Basit, Abdul; Armirotti, Andrea; Scalabrì, Francesco; Pepe, Giuseppe; D'Esposito, Maurizio; Park, Bu-Mahn; Jeong, Sekyoo; Piomelli, Daniele; Maglione, Vittorio Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 87(2016)Supplement 1 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. I08 Passive immunization, with the anti-huntingtin aggregate antibody EM48, is beneficial in R6/2 mouse model. (12th September 2022) Authors: Pepe, Giuseppe; Capocci, Luca; Marracino, Federico; Cicco, Clotilde Di; Scarselli, Pamela; Parlato, Rosanna; Pardo, Alba Di; Maglione, Vittorio Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93(2022)Supplement 1 Page Start: A87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. I10 A genome-wide screening in pluripotent cells identifies MTF1 as a novel suppressor of mutant huntingtin toxicity. (12th September 2022) Authors: Ferlazzo, Giorgia Maria; Gambetta, Anna Maria; Amato, Sonia; Cannizzaro, Noemi; Angiolillo, Silvia; Arboit, Mattia; Galimberti, Elena; Pflug, Florian; Carbognin, Elena; Luoni, Mirko; Giannelli, Serena; Pepe, Giuseppe; Capocci, Luca; Pardo, Alba Di; Broccoli, Vania; Leeb, Martin; Moro, Enrico; Mag... Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93(2022)Supplement 1 Page Start: A88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. I15 Inhibition of S1P degradation is beneficial in the transgenic R6/2 mouse model of huntington disease. (September 2018) Authors: Pardo, Alba Di; Castaldo, Salvatore; Amico, Enrico; Capocci, Luca; Pepe, Giuseppe; Maglione, Vittorio Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89(2018)Supplement 1 Page Start: A93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. I16 Stimulation of SPHK1 with selective activator K6PC-5 is beneficial in the transgenic R6/2 mouse model of huntington disease. (September 2018) Authors: Pardo, Alba Di; Castaldo, Salvatore; Capocci, Luca; Giovannelli, Alfredo; Amico, Enrico; Jeong, Se Kyoo; Maglione, Vittorio Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89(2018)Supplement 1 Page Start: A94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. I17 Curcumin-supplemented diet preserves body weight and ameliorates intestinal functionality in R6/2 mice. (September 2018) Authors: Elifani, Francesca; Castaldo, Salvatore; Capocci, Luca; Rosa, Paolo; Montano, Elena; Calogero, Antonella; Filosa, Stefania; Crispi, Stefania; Maglione, Vittorio; Pardo, Alba Di Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89(2018)Supplement 1 Page Start: A94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. I18 Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase (SGPL1), modulates glycosphingolipid metabolism and results therapeutically effective in a mouse model of Huntington's disease. (12th September 2022) Authors: Pepe, Giuseppe; Capocci, Luca; Marracino, Federico; Realini, Natalia; Scarselli, Pamela; Cicco, Clotilde Di; Armirotti, Andrea; Parlato, Rosanna; Pardo, Alba Di; Maglione, Vittorio Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93(2022)Supplement 1 Page Start: A91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. I19 The defective metabolism of polysialic acid (polysia) may represent an effective therapeutic target in hd pre-clinical models. (12th September 2022) Authors: Pepe, Giuseppe; Capocci, Luca; Marracino, Federico; Moons, Sam J; Sönmez, Aynur; Świtońska-Kurkowska, Karolina; Scarselli, Pamela; Cicco, Clotilde Di; Figiel, Maciej; Boltje, Thomas J; Parlato, Rosanna; Pardo, Alba Di; Maglione, Vittorio Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93(2022)Supplement 1 Page Start: A91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. L14 Inhibition of mitochondrial permeability transition pore (MPTP), by GNX-4728, is beneficial in an in-vitro huntington's disease model. (13th September 2016) Authors: Amico, Enrico; Martinello, Katiusha; Draghi, Federica; Cavalletti, Ennio; Fucile, Sergio; Maglione, Vittorio; Pardo, Alba Di Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 87(2016)Supplement 1 Page Start: A94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗